Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Using Granzyme B-PET Imaging to Predict the Efficacy of Immunotherapy in Locally Advanced and Metastatic Triple-Negative Breast Cancer

NCT07705438 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07705438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Using Granzyme B-PET Imaging to Predict the Efficacy of Immunotherapy in Locally Advanced and Metastatic Triple-Negative Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
May 28, 2025
Completion date
May 28, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

granzyme b pet/ct, immune checkpoint inhibitor, triple negative breast cancer